IMC1C11

Known as: IMC-1C11, IMC-1C11 Chimerized Monoclonal Antibody 
A monoclonal antibody that selectively binds with KDR and blocks the vascular endothelial growth factor-induced endothelial cell proliferation and… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

2000-2007
01220002007

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2008
Review
2008
  • Ka Jia, Jin Li
  • Ai zheng = Aizheng = Chinese journal of cancer
  • 2008
The dependence of tumor growth and metastasis on blood vessels makes tumor angiogenesis a rational target for cancer therapy. One… (More)
Is this relevant?
2007
2007
UNLABELLED The effects of 'metronomic' or extended chemotherapy dosing schedules (ECS) are mediated through poorly understood… (More)
Is this relevant?
2004
2004
The role of angiogenesis in lymphoproliferative diseases is not well established. We demonstrate here that human lymphoma cells… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2003
2003
Vascular endothelial growth factor (VEGF) and its receptors (VEGFR) have been implicated in promoting solid tumor growth and… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 5
Is this relevant?
2003
2003
PURPOSE Angiogenesis plays an important role in colorectal cancer progression. Stimulation of vascular endothelial growth factor… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
2001
2001
ImClone is developing IMC-IC11, an anti-angiogenesis chimeric monoclonal antibody specific vascular endothelial growth factor… (More)
Is this relevant?
Highly Cited
2000
Highly Cited
2000
Emerging data suggest that VEGF receptors are expressed by endothelial cells as well as hematopoietic stem cells. Therefore, we… (More)
  • table 1
  • figure 1
  • figure 3
  • figure 4
  • figure 5
Is this relevant?